Project Grant K08EB037675
Award Date
7/4/25
Completion Date
6/30/29
Dollars Obligated
$191K
Federal Agency
National Institute of Biomedical Imaging and Bioenginering
Awardee
Yale Univ (FL6GV84CKN57)
Federal Grant Program
93.286
Assistance Type
Project Grant
Place of Performance
Connecticut, USA
Similar Awards
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $152,250 to Drexel University to conduct research on using nanoparticles to modulate macrophage metabolism and phenotype for tissue healing and managing chronic inflammation. The key goals are to (1) deliver AC-mimetic metabolites via cyclodextrin nanoparticles to trigger a reparative macrophage state, (2) study the...
The National Institute of General Medical Sciences (NIGMS) awarded a $754,625 Project Grant under the Biomedical Research and Research Training (CFDA 93.859) federal grant program to the University of Florida. The grant, effective September 1, 2024 through June 30, 2029, will fund research to understand the interaction between ultra-small nanoparticles (USNPs) and myeloid cells, such as inflammatory monocytes, and how myeloid cell trafficking can be leveraged to improve the targeting of...
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $851,000 Project Grant under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to the University of North Texas Health Science Center at Fort Worth. The grant supports the development of a novel research tool for accurate and resource-efficient in vivo high-throughput screening of targeted nucleic acid delivery using gene-encapsulated nanoparticles....
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $419,363 Project Grant (CFDA 93.286 - Discovery and Applied Research for Technological Innovations to Improve Human Health) to the Trustees of the Colorado School of Mines, doing business as Colorado School of Mines. This 3-year grant, awarded on April 15, 2025, aims to develop machine learning-guided polymer discovery pipelines for intracellular delivery of ribonucleoproteins (RNPs). The project will engineer...
This Project Grant award, provided by the National Science Foundation (NSF) under its Mathematical and Physical Sciences (CFDA 47.049) program, supports a collaborative research effort to develop microenvironment-sensitive polymeric nanoparticles. The goal is to create nanoparticles that can simultaneously enable targeted drug delivery and provide enhanced ultrasound imaging capabilities. The $272,799 award, effective June 1, 2025 through August 31, 2026, will fund the design and mechanistic...
This $821,426 Project Grant, awarded on January 16, 2025 by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under CFDA 93.286 - Discovery and Applied Research for Technological Innovations to Improve Human Health, is funding research to develop nanostructures that selectively target bacteria and create computational models to predict their activity and behavior. The key objectives are to: Use computer-guided design to create and test antimicrobial nanostructures against...
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $391,588 Project Grant under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" (CFDA 93.286) program to The Methodist Hospital Research Institute (HMRI) in Houston, TX. The grant supports the development of an artificial intelligence-integrated physiologically-based pharmacokinetic (PBPK) model to enable rational design of nanoparticles for improved organ targeting...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855), provides $684,206 to the University of Maryland, Baltimore to develop immunomodulatory nanoparticles (INPs) as a novel therapeutic approach to improve outcomes for patients with sepsis. The primary objectives are to: 1) evaluate the immunomodulatory properties of INPs to maximize therapeutic efficacy in a sepsis...
This National Science Foundation (NSF) Engineering Program project grant awarded to the Massachusetts Institute of Technology (MIT) provides $429,384 in funding to study how drug nanoparticles adhered to leukocyte (white blood cell) surfaces influence their mechanical properties and movement through microscale blood vessel networks. The 5-year research effort, from March 2024 to February 2029, will use a combination of biophysical models and microfluidic experiments to generate fundamental...
This Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports the development of polymer-phage nanoparticle conjugates to treat antibiotic-resistant wound biofilm infections. The $593,860 award to the University of Massachusetts aims to create new phage-polymer nanoparticles that can more effectively penetrate and eradicate bacterial biofilms compared to free phage therapies. The...